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ABSTRACT
Background: Disease maps are an important tool in cancer epidemiology used for the analysis of
geographical variations in disease rates and the investigation of environmental risk factors under-
lying spatial patterns. Cancer maps help epidemiologists highlight geographic areas with high and
low prevalence, incidence, or mortality rates of cancers, and the variability of such rates over a spa-
tial domain. They can also be used to detect “hot-spots” or spatial clusters which may arise due to
common environmental, demographic, or cultural effects shared by neighboring regions. Statisti-
cal methods for spatial data formulate models to capture spatial autocorrelation and produce cancer
maps to better detect clustering and hotspots. When more than one cancer is of interest, the models
must also capture the inherent or endemic association between the diseases in addition to the spa-
tial association. This article develops interpretable and easily implementable spatial autocorrelation
models for two or more cancers.
Methods: The article builds upon recent developments in univariate disease mapping that have
shown the use of mathematical structures such as directed acyclic graphs to capture spatial associa-
tion for a single cancer. The advantage of using directed acyclic graphs over other existing models is
the easier interpretation of spatial association. The current manuscript extends this family of directed
acyclic graphical models to estimate inherent or endemic association for two cancers in addition to
the association over space (clustering) for each of the cancers. The method builds a Bayesian hi-
erarchical model where the spatial effects are introduced as latent random effects for each cancer.
A valid joint probability model is constructed by first modeling the marginal distribution of one
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Spatial Modeling for Correlated Cancers Using Bivariate Directed Graphs
disease followed by the second disease conditional on the first. This approach ensures easier inter-
pretation of model parameters and helps to separate the spatial autocorrelation for each cancer from
the association between the two cancers.
Results: We analyze the relationship between esophagus and lung cancer extracted from the Surveil-
lance, Epidemiology, and End Results (SEER) Program for their incidence rates in the years 2012
- 2016 across 58 counties in California. Our analysis shows statistically significant association
between the county-wise incidence rates of lung and esophagus cancer across California. After ac-
counting for the explanatory variables, esophagus cancer rates exhibit weaker spatial association
than lung cancer rates for data counties in California.
Conclusions: The bivariate directed acyclic graphical model performs better than competing bivari-
ate spatial models in the existing literature. This improvement is seen both in terms of the model’s
fit to the data and complexity of the model.
Keywords: Bayesian hierarchical models; Directed acyclic graphs; Disease mapping; SEER database; Spatial statis-
tics
1 Introduction
Disease mapping, which refers to techniques for mapping and analysis of geographical variations in disease rates and
the investigation of environmental risk factors underlying these patterns, has long been an important tool in cancer
epidemiology (1). Disease maps are used to highlight geographic areas with high and low prevalence, incidence, or
mortality rates of cancers, and the variability of such rates over a spatial domain. They can also be used to detect
“hot-spots” or spatial clusters which may arise due to common environmental, demographic, or cultural effects shared
by neighboring regions. Maps of crude incidence or mortality rates can be misleading when the population sizes
for some of the units are small, which results in large variability in the estimated rates, and makes it difficult to
distinguish chance variability from genuine differences. The correct geographic allocation of health care resources
can be greatly enhanced by deployment of statistical models that allow a more accurate depiction of true disease rates
and their relation to explanatory variables (covariates). Many tasks critical for successful cancer surveillance and
control require new inferential methods to handle these complex and often spatially indexed data sets. Since local
sample sizes within each spatial region are too low for design-based solutions to attain desired levels of statistical
precision (2), much recent work in disease-mapping has been carried out within the context of Bayesian hierarchical
models (3). The body of scientific literature on modern methods for geographic disease mapping is too vast to be
reviewed here. Comprehensive reviews of prevalent statistical disease mapping methods and their implementation
using available software can be found, among several other sources (4, 5, 6, 7).
Statistical models for mapping a single disease have employed probability distributions such as Markov random fields
or MRFs (8) that introduce dependence using the adjacency information among the different regions on a map. Two
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popular examples are the Conditional Autoregression (CAR) and Simultaneous Autoregression (SAR) models (9, 10,
11, 12) for further discussions on CAR and SAR models. More recently, Directed Acyclic Graphical Autoregressive
(DAGAR) models that employ directed acyclic graphs have been developed as a preferred alternative to CAR or
SAR models (13). A specific motivation for DAGAR models is that they impart greater interpretability to the spatial
autocorrelation parameter.
In this article, we will perform joint spatial mapping of two different types of cancers. Joint modeling is appropriate
when different diseases have been observed over the same spatial units and when the diseases themselves are related
to each other, say because they share the same set of spatially distributed risk factors or the presence of one disease in
a spatial unit may encourage or inhibit the presence of the second disease in the same spatial unit. Put differently, we
seek models to capture the spatial association for each disease as well as the association between the diseases. There
is, by now, a substantial literature on multivariate disease mapping (14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24). These
articles have demonstrated, theoretically and empirically, the benefits of jointly modeling several potentially related
cancers, as opposed to modeling them independently. While it has been assertively demonstrated that independent
models for cancers can lead to biased results because of unaccounted associations among the cancers, the current
literature is largely based on using CAR models for spatial mapping. Our proposed bivariate DAGAR model for
modeling two diseases over the same spatial region will help epidemiologists and spatial analysts better interpret the
association among the cancers.
The balance of this article proceeds by developing a class of bivariate DAGAR models, conducting some disease
mapping for two different cancers, and summarizing with some concluding remarks.
2 Methods
Our approach will be to construct a probability model for each disease using the distribution specified by DAGAR.
We will extend the univariate DAGAR to a bivariate model by modeling the distribution of one disease as a univariate
DAGAR and the conditional distribution of the second disease given the first also as a DAGAR. In this sense, our
bivariate DAGAR is analogous to the bivariate CAR models (19). We develop notations and briefly discuss the
univariate DAGAR in the next section, followed by the bivariate extension in the following section.
2.1 DAGAR for modeling a single disease
We consider a geographic map of our region of interest (e.g., a particular state) delineated by k distinct administrative
regions (e.g., counties or ZIP codes) with clear boundaries separating them. Let w = (w1, w2, . . . , wk)> be a k × 1
vector consisting of spatially associated random effects corresponding to each region. We develop a spatially correlated
model using a directed acyclic graph. The geographic map provides us with a list of neighbors for each region.
Neighbors can be defined by the user. Common definitions include when two regions share a common boundary or
if their centers are within a certain fixed distance, although the model and resulting distribution theory hold for any
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fixed set of neighbors. The data structure for the geographic map and its neighbors is defined as a graph, denoted
G = {V, E}, where the regions are indexed by an ordered set V = {1, 2, . . . , k} and form the vertices of the graph
and E is the collection of edges between the vertices, i.e., the collection of ordered pairs (j, j′) such that j and j′ are
geographic neighbors based upon some specified definition.
The DAGAR model specifies w ∼ N(0, τQ(ρ)), where Q(ρ) is a spatial precision matrix that depends only upon
a spatial autocorrelation parameter ρ and τ is a positive scale parameter. To describe Q(ρ), we define neighbor sets
N(i) = {j < i : j ∼ i}, where i ∈ V \ {1}, i.e. the set V excluding the region indexed by 1, and j ∈ V .
Thus, N(i) includes geographic neighbors of region j that precede i in the ordered set V . The precision matrix
Q(ρ) = (I − B)>F (I − B), where B is a k × k strictly lower-triangular matrix with entries bij and F is a k × k
diagonal matrix with diagonal elements fii such that
bij =
 0 if j /∈ N(i) ;ρ
1+(n<i−1)ρ2 if i = 2, 3, . . . , k , j ∈ N(i)
and fii =
1 + (n<i − 1)ρ2
1− ρ2 i = 1, 2 . . . , k , [1]
where n<i is the number of members in N(i). The above definition of bij is consistent with the lower-triangular
structure of B because j /∈ N(i) for any j ≥ i. The derivation of B and F as functions of a spatial correlation
parameter ρ is based upon forming local autoregressive models on embedded spanning trees of subgraphs of G (13).
2.2 A bivariate DAGAR (BDAGAR) model
We now extend the DAGAR to the bivariate case, where we jointly model two cancers across regions. Let wi =
(wi1, wi2, . . . , wik)
> be the spatial random effect vector for disease i, where wij refers to the spatial random effect
for disease i in region j. We will build a hierarchical model,
p(w1, w2) = N(w1 | 0, τ1Q1(ρ1))×N(w2 |A21w1, τ2Q2(ρ2)) , [2]
where N(· |µ,Q) denotes a normal density with mean µ and precision matrix Q. The precision matrices τiQi(ρi) for
i = 1, 2 are the DAGAR precision matrices formed with the entries of B and F described in [1] with ρi. Therefore,
in [2] we model w1 as a univariate DAGAR and w2 conditional on w1 also as a DAGAR. Each disease has its own
distribution and there are two spatial autocorrelation parameters (ρ1 and ρ2) corresponding to the two diseases. This
ensures that spatial associations specific to each disease will be captured.
The matrix A21 models the association between the two diseases. We use a parametric form A21 = η0Ik + η1M ,
where M is the binary adjacency matrix of the geographic map, i.e., mij = 1 if i ∼ j and 0 otherwise. The joint
distribution of w = (w>1 , w
>
2 )
> is now derived from [2] as w ∼ N(0, Qw), where the precision matrix Qw is
Qw =
τ1Q1(ρ1) + τ2A>21Q2(ρ2)A21 τ2A>21Q2(ρ2)
τ2Q2(ρ2)A21 τ2Q2(ρ2)
 [3]
4
Spatial Modeling for Correlated Cancers Using Bivariate Directed Graphs
and the covariance matrix Q−1w is
Q−1w =
 τ−11 Q−11 (ρ1) τ−11 Q−11 (ρ1)A>21
τ−11 A21Q
−1
1 (ρ1) τ
−1
1 A21Q
−1
1 (ρ1)A
>
21 + τ
−1
2 Q
−1
2 (ρ2)
 . [4]
We call a normal distribution with the above precision, or covariance, matrix, the BDAGAR model. The interpretation
of ρ1 and ρ2 is clear: ρ1 measures the spatial association for the first cancer, while ρ2 is the residual spatial correlation
in the second cancer after accounting for the first cancer. Similarly, τ1 is the spatial precision parameter for the first
cancer, while τ2 is the residual precision for the second cancer after accounting for the first.
2.3 Model Implementation
Let yij be our outcome of interest corresponding to cancer i in region j. We will assume that yij is a continuous
variable, e.g., incidence rates, that is related to a set of explanatory variables through the regression model,
yij = x
>
ijβi + wij + ij , [5]
where xij is a pi×1 vector of explanatory variables specific to cancer iwithin region j, βi is the slopes corresponding to
cancer i,wij’s are the spatial effects that collectively follow the bivariate DAGAR distribution described in Section 2.2,
and ij
ind∼ N(0, 1/σ2i ) capture additional heterogeneity and variability independent of spatial variation, where σ2i is
the residual variance for cancer i. The regression model is extended to the following specific Bayesian hierarchical
framework with the posterior distribution p(β,w, η, ρ, τ, σ | y) proportional to
p(ρ)× p(η)×
2∏
i=1
{
IG(1/τi | aτi , bτi)× IG(σ2i | aσ, bσ)×N(βi |µβi , V −1βi )
}
×N(w | 0, Qw)×
2∏
i=1
k∏
j=1
N(yij |x>ijβi + wij , σ2i ) , [6]
where β = {β1, β2}, τ = {τ1, τ2}, σ = {σ21 , σ22} and η = {η0, η1}, and IG(· | a, b) is the inverse-gamma distribution
with shape and rate parameters a and b, respectively.
We sample the parameters from the posterior distribution in [6] using Markov chain Monte Carlo (MCMC) with Gibbs
sampling and random walk metropolis (25) as implemented in the rjags package within the R statistical computing
environment. To compare and assess models, we use the Widely Applicable Information Criterion (WAIC) (26, 27),
which is computed as
WAIC = −2êlppd = −2(l̂ppd− pˆWAIC) ,
where êlppd is the expected log point-wise predictive density for a new dataset and pˆWAIC is the estimated effective
number of parameters, which is sum of posterior variance of the log predictive density for each data point. WAIC is
easy to compute using posterior samples.
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3 Results
We analyze a data set extracted from the SEER∗Stat database using the SEER∗Stat statistical software (28). We
consider 2 cancers, lung and esophagus, where the outcome is the crude incidence rates per 100,000 population in the
years from 2012 to 2016 across 58 counties in California, USA. County-level explanatory variables for each cancer
are available in the same years and include percentages of residents younger than 18 years old (youngij), older than
65 years old (oldij), with education level below high school (eduij) , percentages of unemployed residents (unempij),
black residents (blackij), male residents (maleij), uninsured residents (uninsureij), and percentages of families below
the poverty threshold (povertyij).
We analyzed this data set using the Bayesian hierarchical model [6]. The county-level maps of the raw incidence rates
per 100,000 population for the two cancers are shown in Figure 1. The maps exhibit the evidence of correlation across
space and between cancers. Cutoffs for the different levels of incidence rates are quantiles for each cancer. For both
lung and esophagus cancer, in general, incidence rates are higher in counties located in the northern areas than those in
southern part. The four counties in the center including Amador, Calaveras, Tuolumne and Mariposa have relatively
high incidence rates compared to the neighboring counties. Overall, counties with similar levels of incidence rates
tend to depict some spatial clustering.
For our analysis, we specified the following prior distribution,
p(η, ρ, τ, σ, w) =
2∏
i=1
Unif(ρi | 0, 1)×
1∏
i=0
N(ηi | 0, 102)×
2∏
i=1
N(β | 0, 103)
×
2∏
i=1
IG(1/τi | 2, 0.1)×
2∏
i=1
IG(σ2i | 2, 1)×N(w | 0, Qw(τ, ρ)) , [7]
where Unif(· | a, b) denotes the Uniform density over (0, 1) and Qw(τ, ρ) is the BDAGAR precision matrix of w
given in [3].
We fit the BDAGAR model using the two different cancer orders, i.e. [esophagus] × [lung | esophagus] and the
reverse ordering [lung] × [esophagus | lung]. We will refer to these orderings simply as [lung | esophagus] and
[esophagus | lung], respectively. Table 1 presents measures for model fit using the WAIC. We also compare BDA-
GAR with the “Generalized Multivariate Conditional Autoregression (GMCAR)” models (19). In both BDAGAR and
GMCAR models, the conditional order [esophagus] × [lung | esophagus] has a smaller WAIC (hence better fit to the
data) than the reverse ordering. Meanwhile, within each order, BDAGAR seems to excel over the GMCAR with lower
scores in both model fit and effective number of parameters, as seen in the values of êlppd and pˆWAIC , respectively.
The preference of WAIC for [lung | esophagus] is also corroborated by the posterior distribution of η0 and η1 from
BDAGAR shown in Figure 2. In [esophagus | lung], the parameter η1 has posterior median of −2.73 and a 95% credi-
ble interval (−5.27,−0.81). This shows significant negative values that offset part of the significant positive effect of
η0 with a median of 7.92 and a 95% credible interval of (3.15, 14.60). For [lung | esophagus], η0 is significantly pos-
itive with a median of 16.27 and 95% credible interval of (10.95, 22.09), while η1 tends to be positive with a median
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of 0.87 but with a 95% credible interval (−0.69, 2.43) that includes 0. Consequently, we present the following results
and analysis for [lung | esophagus] which seems to be the preferred model.
Table 2 summarizes the parameter estimates from the BDAGAR model corresponding to [lung | esophagus]. For fixed
effects, the increasing percentage of residents younger than 18 years old significantly reduces the incidence rate for
esophagus cancer, while the percentage of residents older than 65 years old has a significantly opposite effect for both
esophagus and lung cancer. The increase in the percentage of unemployment also augments the incidence rate of lung
cancer significantly. Turning to spatial correlations, ρ1 measures the residual spatial correlation (posterior mean 0.11)
for esophagus cancer after accounting for the explanatory variables and ρ2 measures the spatial correlation (posterior
mean 0.47) for lung cancer after accounting for the explanatory variables and also the effect of esophagus cancer. The
small point estimates and narrower credible interval for ρ1 indicate greater confidence in weaker spatial correlation for
esophagus cancer; the moderate value of ρ2 and a wider credible interval suggest higher spatial correlation for lung
cancer. Turning to the spatial precision of random effects for each cancer, the estimates of {τ1, τ2} are indicative of
esophagus cancer having larger variability, although we must keep in mind that τ2 is the conditional marginal precision
for lung cancer after accounting for esophagus cancer and, therefore, may not be directly comparable to τ1.
Figure 3 shows the estimated correlation between lung and esophagus cancer in each of 58 counties. This map also
seems to be consistent with the estimates of η. Correlations between lung and esophagus cancers in all counties are
significantly positive with large means at around 0.97 − 1 which are due to the highly positive values in η0. This
indicates that esophagus cancer is highly correlated with lung cancer. However, in general, the correlation between
the two cancers increases slightly from the center to marginal areas, especially for those with fewer counties in the
neighborhood.
Finally, Figure 4 provides further visual corroboration of the goodness of fit for the BDAGAR mode corresponding to
[lung | esophagus]. Here, we see that the posterior mean of the incidence rates for lung and esophagus cancer are very
consistent with the raw incidence rates shown in Figure 1.
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Figure 1: Maps of incidence rates per 100,000 population for lung and esophagus cancer in California.
Table 1: Model comparison using WAIC statistics for cancer data analysis
Model lppd pWAIC WAIC
BDAGAR (esophagus | lung) -273.87 44.62 636.99
BDAGAR (lung | esophagus) -158.25 50.27 417.05
GMCAR (esophagus | lung) -282.76 48.23 661.97
GMCAR (lung | esophagus) -158.76 52.33 422.18
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Figure 2: Posterior samples of linking parameters η0, η1 from BDAGAR model.
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Table 2: Parameter estimates (posterior means) for the California cancer incidence rate data from BDAGAR model.
The numbers inside braces indicates the lower and upper bounds for the 95% credible intervals.
Parameters Esophagus cancer Lung cancer
intercept 15.40 (0.45, 30.36) 0.71 (-52.61, 55.17)
young -0.24 (-0.48, -0.01) -0.93 (-2.16, 0.31)
old 0.23 (0.06, 0.41) 2.93 (1.91, 3.98)
edu -0.02 (-0.15, 0.10) -0.39 (-1.22, 0.44)
unemp 0.12 (-0.05, 0.29) 1.41 (0.22, 2.61)
black 0.16 (-0.09, 0.41) 0.87 (-0.84, 2.54)
male -0.06 (-0.23, 0.10) 0.01 (-1.15, 1.16)
uninsure -0.22 (-0.45, 0.02) 0.24 (-0.78, 1.24)
poverty 0.38 (-0.31, 1.07) 0.47 (-3.98, 5.01)
σ2ei 2.31 (1.55, 3.40) 0.88 (0.17, 3.54)
τ2i 2.00 (0.76, 3.84) 19.72 (2.25, 56.18)
ρi 0.11 (0.00, 0.31) 0.47 (0.02, 0.97)
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Figure 3: Estimated correlation between lung and esophagus cancer in each of 58 counties of California.
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Figure 4: Maps of posterior mean incidence rates per 100,000 population for lung and esophagus cancer in California
4 Discussion
We have extended a recently proposed class of DAGAR models (13) for univariate disease mapping to bivariate
“BDAGAR” models that can be applied to estimate spatial correlations for two correlated cancers. The BDAGAR
model retains the interpretation of DAGAR models clearly separating the spatial correlation for each cancer from
any inherent or endemic association between the two cancers. The BDAGAR model can still be efficiently computed
using MCMC algorithms. Our analysis of incidence rates from lung and esophagus cancer demonstrates the efficiency
of BDAGAR and its improved performance, as measured by WAIC, over existing alternatives such as the GMCAR
models.
While we have restricted our attention only to cancer incidence rates, BDAGAR models can also be used with time-
to-event data to investigate geographical patterns in the hazard function. For example, each patient in a study may
provide multiple survival times from the onset of each of two cancers along with his or her county of residence. The
BDAGAR model can become an excellent alternative to CAR and different MCAR models in spatial survival analysis
(29, 17, 30, 31, 21).
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Finally, the BDAGAR models developed here proceeds from conditional specifications. Concerns may arise over the
ordering of the variables in the hierarchical approach. While in the case of a few cancers, such as 2 in our case, one
can evaluate models arising from the different orders, this strategy will become cumbersome with several cancers.
For instance, even with 4 cancers, we will have 24 different models that will need to be evaluated and compared.
This becomes impractical. A joint modeling approach, analogous to order-free MCAR models as in (20), can build
rich spatial structures from linear transformations of simpler latent variables. For instance, we can develop alternate
multivariate DAGAR, or MDAGAR models, using w = Λf , where Λ is a suitably specified square matrix and f is a
latent vector whose components follow independent univariate DAGAR distributions. Note that by modeling the joint
distribution, the incompatibility of conditional model building (i.e., different joint distributions for different orderings)
is avoided. However, the issue of the identifiability of Λ is raised, and careful specification of its structure is needed.
These approaches will be further investigated elsewhere.
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